Menu

Source Legend
  • Human-provided

    Entered or confirmed by an authorized person.

  • Google

    Imported Google information.

  • Trial-derived

    Calculated or extracted directly from associated trial records.

  • AI-inferred

    A capability inferred from trial history.

  • AI-extracted

    An explicit statement extracted from an official source.

  • Public registry

    Information from a public registry.

  • Site record

    Information held in the site record.

Source: Site record. Velocity Clinical Research, Baton Rouge

Verified

Basic Information

Site Overview

Source: Human-provided.

Velocity Clinical Research – Baton Rouge is part of the Velocity Clinical Research integrated site network, delivering comprehensive clinical trial services in Louisiana. The site conducts Phase I–IV clinical studies across a broad range of therapeutic areas, including vaccines, infectious diseases, cardiometabolic disorders, endocrinology, respiratory conditions, and general medicine. Its location in Baton Rouge enables access to a diverse patient population, supporting effective recruitment and strong participant retention. As a member of Velocity’s centralized network, the Baton Rouge site benefits from standardized operating procedures, regulatory expertise, and coordinated quality oversight. The facility supports pharmaceutical and biotechnology sponsors with study start-up, patient enrollment, data collection, and compliance with Good Clinical Practice (GCP) guidelines. With experienced investigators and trained clinical research staff, the site prioritizes participant safety,…

Source: Trial-derived.
17Total Trials
Source: Trial-derived.
2Recruiting Trials
Source: Trial-derived.
5Active Trials
Source: Trial-derived.
12Completed Trials
Source: Trial-derived.
15Unique Conditions
Source: Trial-derived.
9Unique Sponsors

Affiliations

Conditions

Source: Trial-derived. SARS-CoV-2 (4)Source: Trial-derived. Influenza, Human (3)Source: Trial-derived. Dermatitis Atopic (2)Source: Trial-derived. Influenza (2)Source: Trial-derived. Respiratory Syncytial Virus (2)Source: Trial-derived. COVID-19 (1)Source: Trial-derived. Hypertension (1)Source: Trial-derived. Infections (1)

Sponsors

Source: Trial-derived. ModernaTX, Inc. (7)Source: Trial-derived. Seqirus (3)Source: Trial-derived. Sanofi (2)Source: Trial-derived. Biomedical Advanced Research and Development Authority (1)Source: Trial-derived. Currax Pharmaceuticals (1)Source: Trial-derived. Novartis Pharmaceuticals (1)Source: Trial-derived. Novavax (1)Source: Trial-derived. Pfizer (1)

Laboratory & Biospecimens

Laboratory and biospecimen capabilities inferred from trial participation

Source: AI-inferred. PCR / molecular
Source: AI-inferred. Clinical laboratory testing
Source: AI-inferred. Clinical microbiology culture
Source: AI-inferred. Timed pharmacokinetic sampling and processing

Accessibility & Parking

Accessibility Features

Source: Google. Wheelchair accessible entrance
Source: Google. Wheelchair accessible parking lot
Source: Google. Wheelchair accessible restroom

Additional Capabilities

Other capabilities inferred from trial participation

Source: AI-inferred. Cardiac monitoring
Source: AI-inferred. Hemagglutination inhibition (HI) serology assay
Source: AI-inferred. Interferon-gamma release assay (IGRA) tuberculosis testing